TRIM8 and Hepatic steatosis: In the liver, TRIM8 also enhances the K63-linked ubiquitination of TAK1, thus aggravating various hepatic pathophysiological process, including hepatic ischemia /reperfusion injury, hepatic steatosis and fibrosis [30–32].